Mo DC, Huang JF, Luo PH, Chen L, et al. PD-1/PD-L1 inhibitor plus chemotherapy versus standard of care in the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2022 Jul 30. pii: 10.1007/s00405-022-07571.
PMID: 35907001